Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease (Q38327059)

2 September 2017

title

Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease (English)

1 reference

2 September 2017

main subject

myocardial infarction

1 reference

Anderson JL

1

1 reference

2 September 2017

King GJ

2

1 reference

2 September 2017

Bair TL

3

1 reference

2 September 2017

Elmer SP

4

1 reference

2 September 2017

Muhlestein JB

5

1 reference

2 September 2017

Habashi J

6

1 reference

2 September 2017

Carlquist JF

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Journal of the American College of Cardiology

2 September 2017

published in

1 reference

2 September 2017

volume

33

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

727-733

1 reference

Cell adhesion molecules in coronary artery disease

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Platelet activation in unstable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

"Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY"

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Serological and genetical studies on a platelet antigen (Zw)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Isolation and immunologic characterization of the human platelet alloantigen, P1A1

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900603-2

7 January 2021

10.1016/S0735-1097(98)00603-2

Identifiers

DOI

1 reference

2 September 2017

1 reference